Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37412294> ?p ?o ?g. }

Showing items 1 to 100 of ±121 with 100 items per page.

Q37412294 description "article científic" @default.
Q37412294 description "article scientifique" @default.
Q37412294 description "articolo scientifico" @default.
Q37412294 description "artigo científico" @default.
Q37412294 description "artículu científicu espublizáu en 2009" @default.
Q37412294 description "bilimsel makale" @default.
Q37412294 description "scientific article published on 21 September 2009" @default.
Q37412294 description "vedecký článok" @default.
Q37412294 description "vetenskaplig artikel" @default.
Q37412294 description "videnskabelig artikel" @default.
Q37412294 description "vědecký článek" @default.
Q37412294 description "wetenschappelijk artikel" @default.
Q37412294 description "wissenschaftlicher Artikel" @default.
Q37412294 description "наукова стаття, опублікована у вересні 2009" @default.
Q37412294 description "научни чланак" @default.
Q37412294 description "գիտական հոդված հրատարակված 2009 թվականի սեպտեմբերի 21-ին" @default.
Q37412294 description "مقالة علمية نشرت في 21 سبتمبر 2009" @default.
Q37412294 name "Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803." @default.
Q37412294 name "Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803." @default.
Q37412294 name "Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803." @default.
Q37412294 type Item @default.
Q37412294 label "Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803." @default.
Q37412294 label "Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803." @default.
Q37412294 label "Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803." @default.
Q37412294 prefLabel "Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803." @default.
Q37412294 prefLabel "Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803." @default.
Q37412294 prefLabel "Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803." @default.
Q37412294 P1433 Q37412294-2E559F5B-734C-4715-8C3E-A0A4B79BF674 @default.
Q37412294 P1476 Q37412294-1A05959F-6CE7-450F-AC22-FB6C7BB19F4D @default.
Q37412294 P2093 Q37412294-0B3FE7E2-88C6-47EC-A189-D8312B560A93 @default.
Q37412294 P2093 Q37412294-44EDD1B4-89B9-499B-925B-3DC566D3F8B4 @default.
Q37412294 P2093 Q37412294-4EFF397D-3455-4F0F-95B0-2E04AC051EB9 @default.
Q37412294 P2093 Q37412294-548B029C-97B2-47FF-A75A-1A402F1DC833 @default.
Q37412294 P2093 Q37412294-8D56E24D-A933-49B1-9C3C-113559819D52 @default.
Q37412294 P2093 Q37412294-9065487E-EDDF-482E-BFEF-2ABB0076C1EC @default.
Q37412294 P2093 Q37412294-9F370F48-20BB-4B13-89AE-4E01DA97E49E @default.
Q37412294 P2093 Q37412294-B30F0B9D-9F4D-412E-B69A-2C5B5F668E59 @default.
Q37412294 P2093 Q37412294-DF576EFC-8183-4043-BF81-764DBB8ACA60 @default.
Q37412294 P2860 Q37412294-11256089-A265-46BE-A7A0-6E0D972DCFF3 @default.
Q37412294 P2860 Q37412294-22D93B27-A142-4D6A-8434-178DEBA3E3C6 @default.
Q37412294 P2860 Q37412294-36A7E4DE-A5CE-43FE-ABD9-94AF4E0C6340 @default.
Q37412294 P2860 Q37412294-392B662F-A59B-40E7-97CA-212E2396BD2D @default.
Q37412294 P2860 Q37412294-65B8882A-E71A-43B2-B3BB-34AA8B747E5D @default.
Q37412294 P2860 Q37412294-7554A5C7-2373-4FEF-A5AB-70F4C9A3CFA5 @default.
Q37412294 P2860 Q37412294-8296E875-25BE-4B8E-A271-53937877E8FB @default.
Q37412294 P2860 Q37412294-8D6B4AA5-4344-48F0-AA41-60321676765C @default.
Q37412294 P2860 Q37412294-8E728D6A-7307-4B6B-B4A9-08A2CBCED982 @default.
Q37412294 P2860 Q37412294-997533E8-AF0C-429D-94D0-804C8CF1078D @default.
Q37412294 P2860 Q37412294-9A235561-319B-481D-BB43-88D060346149 @default.
Q37412294 P2860 Q37412294-A83B8FF4-D37C-44AC-8D49-CD7669284DEF @default.
Q37412294 P2860 Q37412294-ACADD58E-F0DE-48C1-B4FC-910863675135 @default.
Q37412294 P2860 Q37412294-BCEDE10B-11CD-4847-BE83-C8F6B6CC979C @default.
Q37412294 P2860 Q37412294-BE46EC63-C14B-469F-B247-098E9E6E933D @default.
Q37412294 P2860 Q37412294-D48D842E-A4EA-4F7C-9F4D-59F6B1A6988A @default.
Q37412294 P2860 Q37412294-D69AF102-184C-4815-A0C8-FF57C88396AF @default.
Q37412294 P2860 Q37412294-E0EF9A10-A1E5-4F51-8B16-E7C7E21B08F0 @default.
Q37412294 P2860 Q37412294-E5BEC6D2-8351-4093-A474-65491337D453 @default.
Q37412294 P2860 Q37412294-F252E4D9-5EED-4DDB-A9A8-67421C0EEE9B @default.
Q37412294 P2860 Q37412294-FBC59249-0284-4569-AD27-41329C4A810D @default.
Q37412294 P304 Q37412294-9302BF8C-D414-4754-A86D-F6E2675C4069 @default.
Q37412294 P31 Q37412294-FD5E11B2-6A0F-44E8-8782-332F62673E34 @default.
Q37412294 P356 Q37412294-63538732-CE11-49B1-BA46-11EF0A6F785A @default.
Q37412294 P407 Q37412294-9F0644CE-D5E6-4886-8835-48FDD454C8D6 @default.
Q37412294 P433 Q37412294-93928B1A-B97E-4364-949B-A3336B17AFAF @default.
Q37412294 P478 Q37412294-CE8B16BB-7894-4427-A881-7CFBE0198986 @default.
Q37412294 P50 Q37412294-11316472-6E53-44E3-AFFE-6A71A7BD83AC @default.
Q37412294 P50 Q37412294-1FC976A9-D5B5-4BF4-ABF1-8D71221F0CA5 @default.
Q37412294 P50 Q37412294-40360C1A-10C0-4AC8-B024-4895CBFBEA68 @default.
Q37412294 P50 Q37412294-D7D98209-93C7-4CA9-92C7-3DBD768BE110 @default.
Q37412294 P577 Q37412294-EFCBD0A9-553F-4650-8624-EFFBC64FFA26 @default.
Q37412294 P698 Q37412294-A8E3B1B2-DF75-4164-B55B-FADB99DCC5F5 @default.
Q37412294 P921 Q37412294-4A25A052-B0F5-4009-8D8C-20A9CAA9E7B8 @default.
Q37412294 P932 Q37412294-DEC7B8BD-EED4-4986-AC85-6C74BC5B031D @default.
Q37412294 P356 JCO.2009.22.3768 @default.
Q37412294 P698 19770373 @default.
Q37412294 P1433 Q400292 @default.
Q37412294 P1476 "Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803." @default.
Q37412294 P2093 "Andrea A Hayes-Jordan" @default.
Q37412294 P2093 "Carola A S Arndt" @default.
Q37412294 P2093 "Charles N Paidas" @default.
Q37412294 P2093 "David A Rodeberg" @default.
Q37412294 P2093 "David M Parham" @default.
Q37412294 P2093 "John C Breneman" @default.
Q37412294 P2093 "Julie A Stoner" @default.
Q37412294 P2093 "Lisa A Teot" @default.
Q37412294 P2093 "Sarah S Donaldson" @default.
Q37412294 P2860 Q24569561 @default.
Q37412294 P2860 Q33335538 @default.
Q37412294 P2860 Q33951643 @default.
Q37412294 P2860 Q34171661 @default.
Q37412294 P2860 Q34302301 @default.
Q37412294 P2860 Q34361516 @default.
Q37412294 P2860 Q34532243 @default.
Q37412294 P2860 Q34879307 @default.
Q37412294 P2860 Q42549090 @default.
Q37412294 P2860 Q42558230 @default.
Q37412294 P2860 Q42804296 @default.
Q37412294 P2860 Q44320806 @default.
Q37412294 P2860 Q44790661 @default.
Q37412294 P2860 Q44895894 @default.